Breast Cancer

, Volume 18, Issue 1, pp 64–67

Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach

  • Masahiro Takada
  • Hiroshi Terunuma
  • Xuewen Deng
  • Md. Zahidunnabi Dewan
  • Shigehira Saji
  • Katsumasa Kuroi
  • Naoki Yamamoto
  • Masakazu Toi
Case Report

DOI: 10.1007/s12282-010-0198-5

Cite this article as:
Takada, M., Terunuma, H., Deng, X. et al. Breast Cancer (2011) 18: 64. doi:10.1007/s12282-010-0198-5

Abstract

A suggestive case of metastatic disease from breast cancer is reported. The HER-2-positive tumor was refractory to several agents, including anti-HER-2 therapy, trastuzumab, and lapatinib. After re-induction of trastuzumab in combination with activated natural killer (NK) cell injection therapy, tumor markers decreased, and finally a synergistic effect of taxane and capecitabine led to treatment response. This case suggests that multidisciplinary therapy including an immunological approach might be a breakthrough in the treatment of refractory disease.

Keywords

Breast cancer Metastasis Natural killer cell Chemotherapy Trastuzumab 

Copyright information

© The Japanese Breast Cancer Society 2010

Authors and Affiliations

  • Masahiro Takada
    • 1
  • Hiroshi Terunuma
    • 2
    • 3
  • Xuewen Deng
    • 2
  • Md. Zahidunnabi Dewan
    • 4
  • Shigehira Saji
    • 5
  • Katsumasa Kuroi
    • 5
  • Naoki Yamamoto
    • 6
    • 7
  • Masakazu Toi
    • 1
  1. 1.Department of Breast Surgery, Graduate School of MedicineKyoto UniversityKyotoJapan
  2. 2.Biotherapy Institute of JapanTokyoJapan
  3. 3.Tokyo Clinic Marunouchi OazoTokyoJapan
  4. 4.Department of PathologyNew York University Medical CenterNew YorkUSA
  5. 5.Department of SurgeryTokyo Metropolitan Cancer and Infectious Diseases Center, Komagome HospitalTokyoJapan
  6. 6.Department of Molecular VirologyTokyo Medical and Dental UniversityTokyoJapan
  7. 7.National Institute of Infectious DiseasesTokyoJapan

Personalised recommendations